Denna sida på svenska
Loading profile information...

About me

I’m born in Sweden 1981 and graduated from Medical School 2005 (Karolinska Institutet). In 2008, I defended my PhD-thesis “Mesenchymal Stromal Cell Transplantation: Possible Viral Complications and Alloimmunity” (Karolinska Institutet). In 2016, I was appointed Associate Professor of Pediatrics (Karolinska Institutet).

My clinical training (Internship and Residency) took place at the Karolinska University Hospital and the Astrid Lindgren Children’s Hospital, respectively. Currently, I work as Senior Consultant in Pediatric Hematology/Oncology and Medical Director at the services for Pediatric Blood Disorders/Immunodeficiency/Stem Cell Transplantation at Astrid Lindgren Children’s Hospital.

I’m Research Group Leader (PI) at the Division of Pediatrics, CLINTEC, Karolinska Institutet. The research is mainly focused on pediatric stem cell transplantation and the immune recovery with special reference to humoral and innate immunity. I’m supervising several PhD-students. Moreover, I’ve a research interest in tick-borne CNS infections.

Publications

Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors
Wang T, Remberger M, Axdorph Nygell U, Sundin M, Björklund A, Mattsson J, et al
Transfusion 2018;58(6):1442-1451

Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis
Swartling L, Ljungman P, Remberger M, Sundin M, Tiveljung A, Mattsson J, et al
Transplant infectious disease : an official journal of the Transplantation Society 2018;20(2):e12847-

Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition
Stikvoort A, Gaballa A, Solders M, Nederlof I, Önfelt B, Sundberg B, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018;24(3):467-477

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A, Chen Y, Rådestad E, Törlén J, Lakshmikanth T, Björklund A, et al
Frontiers in immunology 2017;8():717-

Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation
Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle Jh, Cornish J, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017;23(3):467-474

No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies
Magalhaes I, Uhlin M, Schaffer M, Sundin M, Hauzenberger D, Remberger M, et al
Clinical transplantation 2017;31(8):-

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Herold N, Rudd Sg, Ljungblad L, Sanjiv K, Myrberg Ih, Paulin Cb, et al
Nature medicine 2017;23(2):256-263

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M, Törlen J, Serafi Ie, Garming-legert K, Björklund A, Ljungman P, et al
International journal of hematology 2017;106(4):471-475

HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT
Thorvaldson L, Remberger M, Winiarski J, Omazic B, Fischler B, Sundin M
Pediatric transplantation 2016;20(1):96-104

Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades
Svenberg P, Remberger M, Uzunel M, Mattsson J, Gustafsson B, Fjaertoft G, et al
Pediatric transplantation 2016;20(5):667-74

Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
Bresters D, Lawitschka A, Cugno C, Pötschger U, Dalissier A, Michel G, et al
Bone marrow transplantation 2016;51(11):1482-1489

Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al
PloS one 2016;11(5):e0154737-

Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis
Walne Aj, Collopy L, Cardoso S, Ellison A, Plagnol V, Albayrak C, et al
Haematologica 2016;101(10):1180-1189

Sofosbuvir and Simeprevir Treatment of a Stem Cell Transplanted Teenager With Chronic Hepatitis C Infection
Fischler B, Priftakis P, Sundin M
The Pediatric infectious disease journal 2016;35(6):708-10

Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Kreins Ay, Ciancanelli Mj, Okada S, Kong Xf, Ramírez-alejo N, Kilic Ss, et al
The Journal of experimental medicine 2015;212(10):1641-62

Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
Sundin M, Remberger M, Lindqvist H, Omazic B, Sundberg B, Uzunel M, et al
Pediatric blood & cancer 2015;62(5):890-6

Neutropenia in childhood: a 5-year experience at a tertiary center
Lindqvist H, Carlsson G, Moell J, Winiarski J, Sundin M
European journal of pediatrics 2015;174(6):801-7

Prenatal acquired cytomegalovirus infection should be considered in children with autism
Engman Ml, Sundin M, Miniscalco C, Westerlund J, Lewensohn-fuchs I, Gillberg C, et al
Acta paediatrica (Oslo, Norway : 1992) 2015;104(8):792-5

Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
Watz E, Remberger M, Ringden O, Ljungman P, Sundin M, Mattsson J, et al
Transfusion 2015;55(10):2339-50

Tick-borne encephalitis as a notifiable disease--Status quo and the way forward. Report of the 17th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)
Isw Tbe, Kunze U
Ticks and tick-borne diseases 2015;6(5):545-8

Cesarean delivery and hematopoietic stem cell epigenetics in the newborn infant: implications for future health?
Almgren M, Schlinzig T, Gomez-cabrero D, Gunnar A, Sundin M, Johansson S, et al
American journal of obstetrics and gynecology 2014;211(5):502.e1-8

Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology
Sundin M, Tesi B, Sund Böhme M, Bryceson Yt, Pütsep K, Chiang Sc, et al
Journal of clinical immunology 2014;34(4):469-77

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M, Wikell H, Sundin M, Blennow O, Maeurer M, Ringden O, et al
Haematologica 2014;99(2):346-52

The European Society for Immunodeficiencies (ESID) registry 2014
Esid Registry Working Party, Grimbacher B
Clinical and experimental immunology 2014;178 Suppl 1():18-20

The PedPAD study: boys predominate in the hypogammaglobulinaemia registry of the ESID online database
Pedpad Consortium, Schatorjé Ej, Gathmann B, Van Hout Rw, De Vries E
Clinical and experimental immunology 2014;176(3):387-93

Tick-borne encephalitis - a notifiable disease, a review after one year: report of the 16th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)
Isw-tbe, Kunze U
Ticks and tick-borne diseases 2014;5(5):453-6

Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantation
Hansson Me, Norlin Ac, Omazic B, Wikström Ac, Bergman P, Winiarski J, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014;20(10):1537-43

Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients
Stikvoort A, Gertow J, Sundin M, Remberger M, Mattsson J, Uhlin M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):838-44

Folinic acid supplementation in higher doses is associated with graft rejection in pediatric hematopoietic stem cell transplantation
Lindqvist H, Remberger M, Harila-saari A, Winiarski J, Sundin M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):325-8

[TBE (tick-borne encephalitis) in childhood--is it dangerous?]
Lidefelt Kj, Lindquist L, Engman Ml, Sundin M
Lakartidningen 2013;110(9-10):452-3

Tick-borne encephalitis--a notifiable disease: report of the 15th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)
Isw-tbe, Kunze U
Ticks and tick-borne diseases 2013;4(5):363-5

One-year Follow-up of Tick-borne Central Nervous System Infections in Childhood
Engman Ml, Lindstrom K, Sallamba M, Hertz C, Sundberg B, Hansson Mea, et al
PEDIATRIC INFECTIOUS DISEASE JOURNAL 2012;31(6):570-4

Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations
Sundin M, Hansson Mea, Engman Ml, Orvell C, Lindquist L, Wide K, et al
EUROPEAN JOURNAL OF PEDIATRICS 2012;171(2):347-52

Subcutaneous IgG replacement after pediatric SCT
Sundin M, Nordin K, Jostemyr Y, Winiarski J
Pediatric transplantation 2012;16(8):866-71

Tick-borne encephalitis (TBE): an underestimated risk…still: report of the 14th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE)
Isw-tbe, Kunze U
Ticks and tick-borne diseases 2012;3(3):197-201

Multipotent Mesenchymal Stromal Cells Express FoxP3: A Marker for the Immunosuppressive Capacity?
Sundin M, D'arcy P, Johansson Cc, Barrett Aj, Lonnies H, Sundberg B, et al
JOURNAL OF IMMUNOTHERAPY 2011;34(4):336-42

TICK-BORNE ENCEPHALITIS IN CHILDHOOD RARE OR MISSED?
Hansson Mea, Orvell C, Engman Ml, Wide K, Lindquist L, Lidefelt Kj, et al
PEDIATRIC INFECTIOUS DISEASE JOURNAL 2011;30(4):355-7

HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor
Sundin M, Barrett Aj, Ringden O, Uzunel M, Lonnies H, Dackland Al, et al
JOURNAL OF IMMUNOTHERAPY 2009;32(7):755-64

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H, Hagglund H, Gustafsson-jernberg A, Leblanc K, Mattsson J, Remberger M, et al
TRANSPLANT INFECTIOUS DISEASE 2009;11(5):393-9

No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells
Sundin M, Remberger M, Lonnies H, Sundberg B, Ringden O, Le Blanc K
CYTOTHERAPY 2008;10(3):238-42

Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: Implications for transplantation
Sundin M, Lindblom A, Orvell C, Barrett Aj, Sundberg B, Watz E, et al
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 2008;14(10):1172-1179

Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum
Le Blanc K, Samuelsson H, Lonnies L, Sundin M, Ringden O
TRANSPLANTATION 2007;84(8):1055-9

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients
Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2007;92(9):1208-15

Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual
Sundin M, Orvell C, Rasmusson I, Sundberg B, Ringden O, Le Blanc K
BONE MARROW TRANSPLANTATION 2006;37(11):1051-9

The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation
Sundin M, Le Blanc K, Ringden O, Barkholt L, Omazic B, Lergin C, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2006;91(8):1059-67

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes
Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2004;60(3):307-15

Show all publications